The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia

Delphine Verbeke; Sofie Demeyer; Cristina Prieto; Charles E. de Bock; Jolien De Bie; Olga Gielen; Kris Jacobs; Nicole Mentens; Bronte Manouk Verhoeven; Anne Uyttebroeck; Nancy Boeckx; Kim De Keersmaecker; Johan Maertens; Heidi Segers; Jan Cools

doi:10.1158/1078-0432.CCR-20-1315

Translational Cancer Mechanisms and Therapy

The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia

Delphine Verbeke, Sofie Demeyer, Cristina Prieto, Charles E. de Bock, Jolien De Bie, Olga Gielen, Kris Jacobs, Nicole Mentens, Bronte Manouk Verhoeven, Anne Uyttebroeck, Nancy Boeckx, Kim De Keersmaecker, Johan Maertens, Heidi Segers and Jan Cools

Delphine Verbeke

1Center for Human Genetics, KU Leuven, Leuven, Belgium.

2Center for Cancer Biology, VIB, Leuven, Belgium.

3Leuvens Kanker Instituut (LKI), KU Leuven – UZ Leuven, Leuven, Belgium.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sofie Demeyer

1Center for Human Genetics, KU Leuven, Leuven, Belgium.

2Center for Cancer Biology, VIB, Leuven, Belgium.

3Leuvens Kanker Instituut (LKI), KU Leuven – UZ Leuven, Leuven, Belgium.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Cristina Prieto

1Center for Human Genetics, KU Leuven, Leuven, Belgium.

2Center for Cancer Biology, VIB, Leuven, Belgium.

3Leuvens Kanker Instituut (LKI), KU Leuven – UZ Leuven, Leuven, Belgium.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Charles E. de Bock

4Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Randwick, New South Wales, Australia.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Charles E. de Bock

Jolien De Bie

1Center for Human Genetics, KU Leuven, Leuven, Belgium.

2Center for Cancer Biology, VIB, Leuven, Belgium.

3Leuvens Kanker Instituut (LKI), KU Leuven – UZ Leuven, Leuven, Belgium.

5Department of Laboratory Medicine, UZ Leuven, Leuven, Belgium.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Olga Gielen

1Center for Human Genetics, KU Leuven, Leuven, Belgium.

2Center for Cancer Biology, VIB, Leuven, Belgium.

3Leuvens Kanker Instituut (LKI), KU Leuven – UZ Leuven, Leuven, Belgium.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kris Jacobs

1Center for Human Genetics, KU Leuven, Leuven, Belgium.

2Center for Cancer Biology, VIB, Leuven, Belgium.

3Leuvens Kanker Instituut (LKI), KU Leuven – UZ Leuven, Leuven, Belgium.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nicole Mentens

1Center for Human Genetics, KU Leuven, Leuven, Belgium.

2Center for Cancer Biology, VIB, Leuven, Belgium.

3Leuvens Kanker Instituut (LKI), KU Leuven – UZ Leuven, Leuven, Belgium.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bronte Manouk Verhoeven

1Center for Human Genetics, KU Leuven, Leuven, Belgium.

2Center for Cancer Biology, VIB, Leuven, Belgium.

3Leuvens Kanker Instituut (LKI), KU Leuven – UZ Leuven, Leuven, Belgium.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anne Uyttebroeck

3Leuvens Kanker Instituut (LKI), KU Leuven – UZ Leuven, Leuven, Belgium.

6Department of Pediatric Oncology, UZ Leuven, Leuven, Belgium.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nancy Boeckx

5Department of Laboratory Medicine, UZ Leuven, Leuven, Belgium.

7Department of Oncology, KU Leuven, Leuven, Belgium.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kim De Keersmaecker

3Leuvens Kanker Instituut (LKI), KU Leuven – UZ Leuven, Leuven, Belgium.

7Department of Oncology, KU Leuven, Leuven, Belgium.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Kim De Keersmaecker

Johan Maertens

3Leuvens Kanker Instituut (LKI), KU Leuven – UZ Leuven, Leuven, Belgium.

8Department of Hematology, UZ Leuven, Leuven, Belgium.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Heidi Segers

3Leuvens Kanker Instituut (LKI), KU Leuven – UZ Leuven, Leuven, Belgium.

6Department of Pediatric Oncology, UZ Leuven, Leuven, Belgium.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jan Cools

1Center for Human Genetics, KU Leuven, Leuven, Belgium.

2Center for Cancer Biology, VIB, Leuven, Belgium.

3Leuvens Kanker Instituut (LKI), KU Leuven – UZ Leuven, Leuven, Belgium.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Jan Cools
For correspondence: jan.cools@kuleuven.be

DOI: 10.1158/1078-0432.CCR-20-1315 Published November 2020

Article
Figures & Data
Info & Metrics
PDF

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

PreviousNext

November 2020
Volume 26, Issue 21

Table of Contents
Table of Contents (PDF)
About the Cover
Editorial Board (PDF)

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia

Message Subject (Your Name) has forwarded a page to you from Clinical Cancer Research

Message Body (Your Name) thought you would be interested in this article in Clinical Cancer Research.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia

Clin Cancer Res November 1 2020 (26) (21) 5747-5758; DOI: 10.1158/1078-0432.CCR-20-1315

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia

Clin Cancer Res November 1 2020 (26) (21) 5747-5758; DOI: 10.1158/1078-0432.CCR-20-1315

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Main menu

User menu

Search

The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia

Purchase access

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Articles

Info for

About Clinical Cancer Research